AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery

Biotechnology and Bioengineering

Volumn 109, Issue 11, 2012, Pages 2920-2931

  Aravind, Athulya ^a   Jeyamohan, Prashanti ^a   Nair, Remya ^a   Veeranarayanan, Srivani ^a   Nagaoka, Yutaka ^a   Yoshida, Yasuhiko ^a   Maekawa, Toru ^a   Kumar, D Sakthi ^a  

^a TOYO UNIVERSITY   (Japan)

Author keywords

AS1411 aptamer; Drug release; Liposomes; Paclitaxel; PLGA nanoparticles; Targeted drug delivery

Indexed keywords

APTAMERS; DRUG RELEASE; PACLITAXEL; PLGA NANOPARTICLES; TARGETED DRUG DELIVERY;

BIODEGRADABLE POLYMERS; CELL CULTURE; CELLS; CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY; DRUG PRODUCTS; ENCAPSULATION; LIPOSOMES; NANOPARTICLES; PARTICLE SIZE ANALYSIS; PHOSPHOLIPIDS; PHOTOELECTRONS; SYNTHESIS (CHEMICAL); TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

COPOLYMERS;

APTAMER; MACROGOL; NANOPARTICLE; NUCLEOLIN; PACLITAXEL; PHOSPHATIDYLCHOLINE; POLYGLACTIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NANOENCAPSULATION; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL; ULTRAVIOLET SPECTROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; DRUG CARRIERS; FLOW CYTOMETRY; HUMANS; LACTIC ACID; LECITHINS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; PHOTOELECTRON SPECTROSCOPY; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 84866759245     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.24558     Document Type: Article

References (34)

1. Aravind A, Varghese SH, Veeranarayanan S, Mathew A, Nagaoka Y, Iwai S, Fukuda T, Hasumura T, Yoshida Y, Maekawa T, SakthiKumar D. 2012. Aptamer-labeled PLGA nanoparticles for targeting cancer cells. Cancer Nano DOI 10.1007/s12645-011-0024-6.
2. Bates PJ, Laber D, et al. 2009. Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol 86(3): 151-164, DOI: 10.1016/j.yexmp.2009.01.004.
3. Cartiera MS, Ferreira EC, Caputo C, Egan ME, Caplan MJ, Saltzman WM. 2010. Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin. Mol Pharm 7(1): 86-93, DOI: 10.1021/mp900138a.
4. Chan JM, Zhang L, Yuet KP, et al. 2009. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30(8): 1627-1634.
5. Chan JM, Rhee J-W, Drumc CL, et al. 2011. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci USA 108(48): 19347-19352.
6. Corti A, Pastorino F, Curnis F, et al. 2011. Targeted drug delivery and penetration into solid tumors. Med Res Rev 1-14, DOI: 10.1002/med.
7. Danhier F, Lecouturier N, Vroman B, et al. 2009a. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Control Release 133(1): 11-17.
8. Danhier F, Vroman B, Lecouturier N, et al. 2009b. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release 140(2): 166-173.
9. Fang RH, Aryal S, Hu CMJ, Zhang L. 2010. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 26(22): 16958-16962, DOI: 10.1021/la103576a.
10. Feng SS, Huang G. 2001. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 71(1): 53-69.
11. Fonseca C, Simões S, Gaspar R. 2002. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83(2): 273-286.
12. Gradishar WJ, Tjulandin S, Davidson N, et al. 2005. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23(31): 7794-7803.
13. Gregoriadis G. 1995. Engineering liposomes for drug delivery: Progress and problems. Trends Biotechnol 13(12): 527-537, DOI: 10.1016/S0167-7799(00)89017-4.
14. Hu CMJ, Kaushal S, Cao HST, et al. 2010. Nanoparticles for targeted drug delivery to. Mol Pharm 7(3): 914-920.
15. Ireson CR, Kelland LR. 2006. Discovery and development of anticancer aptamers. Mol Cancer Ther 5(12): 2957-2962, DOI: 10.1158/1535-7163.MCT-06-0172.
16. Liu Y, Pan J, Feng SS. 2010a. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance. Int J Pharm 395(1-2): 243-250, DOI: 10.1016/j.ijpharm.2010.05.008.
17. Liu Y, Li K, Liu B, Feng SS. 2010b. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 31(35): 9145-9155. DOI: 10.1016/j.biomaterials.2010.08.053.
18. López-Colón D, Jiménez E, You M, Gulbakan B, Tan W. 2011. Aptamers: Turning the spotlight on cells. Wiley interdisciplinary reviews. Nanomed Nanobiol 3(3): 328-340, DOI: 10.1002/wnan.133.
19. Malam Y, Loizidou M, Seifalian AM. 2009. Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11): 592-599, DOI: 10.1016/j.tips.2009.08.004.
20. Mu L, Feng SS. 2002. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release 80(1-3): 129-144.
21. Mukerjee A, Vishwanatha JK. 2009. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 29(10): 3867-3875.
22. Park JW. 2002. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 4(3): 95-99.
23. Ray P, White RR. 2010. Aptamers for targeted drug delivery. Pharmaceuticals 3(6): 1761-1778, DOI: 10.3390/ph3061761.
24. Sahay G, Alakhova DY, Kabanov AV. 2010. Endocytosis of nanomedicine. J Control Release 145: 182-195.
25. Sosnik A, Carcaboso AM, Chiappetta D. 2010. Polymeric nanocarriers: New endeavors for the optimization of the technological aspects of drugs. Recent Patents Biomed Engin 1(1): 43-59, DOI: 10.2174/1874764710801010043.
26. Soundararajan S, Wang L, Sridharan V, et al. 2009. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Leuk Lymphoma 76(5): 984-991, DOI: 10.1124/mol.109.055947.
27. Sun BF, Feng SS. 2009. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of Docetaxel. Nanomedicine 4(4): 431-445.
28. Thamake SI, Raut SL, Ranjan P, Gryczynski Z, Vishwanatha JK. 2011. Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy. Nanotechnology 22(3): 035101, DOI: 10.1088/0957-4484/22/3/035101.
29. Valencia PM, Basto PA, Zhang L, Rhee M, Langer R, Farokhzad OC, Karnik R. 2010. Single-step assembly of homogenous lipid polymeric and lipid quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano 4(3): 1671-1679.
30. Wang H, Zhao P, Liang X, et al. 2010. Folate-PEG coated cationic modified chitosan-cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 31(14): 4129-4138, DOI: 10.1016/j.biomaterials.2010.01.089.
31. Xu P, Gullotti E, Tong L, et al. 2009. Intracellular drug delivery by poly (lactic-co-glycolic acid) nanoparticles, revisited. Mol Pharm 6(1): 190-201.
32. Yu C, Hu Y, Duan J, Yuan W, Wang C, Xu H, Yang XD. 2011. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro. PloS ONE 6(9): 24077, DOI: 10.1371/journal.pone.0024077.
33. Zhang L, Chan JM, Gu FX, et al. 2008. Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform. ACS Nano 2(8): 1696-1702.
34. Zhao P, Wang H, Yu M, et al. 2010. Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: In vitro and in vivo evaluation. Pharm Res 27: 1914-1926.